Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 385D (ZNF385D) is a sequence-specific DNA-binding transcription factor belonging to the C2H2-type zinc finger superfamily, localized in the nucleus and predicted to be crucial for neural development—particularly in processes underlying higher order language and communication[1][3]. Genome-wide association studies have found significant links between variations in ZNF385D and co-occurring reading disability and language impairment, implicating this factor in the regulation of genes essential for the formation of neural circuits and brain connectivity supporting language acquisition. ZNF385D is not recognized as a canonical pharmacological target such as a receptor, enzyme, or transporter, nor are there approved drugs that act upon it or established safety concerns documented in the current literature[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 385D (ZNF385D).